Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$1.9MFederal grants as PI3 awards
1Patents grantedLatest Jun 1, 2021
25Papers796 citations
Federal awards and patents by year
AwardsPatents
3 awards · $1.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 18, 2025 | NIH | SBIR Phase II A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy | $625K | SERPIN PHARMA, LLC |
| Sep 16, 2024 | NIH | SBIR Phase II A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy | $839K | SERPIN PHARMA, LLC |
| Sep 19, 2022 | NIH | SBIR Phase I Pre-clinical validation of Phase II peptide LRP-1 agonist to treat and prevent chemotherapy induced peripheral neuropathy. | $399K | SERPIN PHARMA, LLC |
2 patents as inventor
- US 11020462SERPIN PHARMA, LLCJun 1, 2021
- US SERPIN PHARMA, LLC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,137
Awards as PI#822
Patents#155
Companies
- SERPIN PHARMA, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.